Scinai Reorganizes to Launch CDMO Platform and Lean R&D
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI); (“Scinai” or the “Company”), a biopharmaceutical company developing inflammation and immunology therapeutics and operating a growing CDMO business, today announced the completion...